Indian Journal for Research in Law and Management
Advancing Law and Management
ISSN No. : 2583-9896
ISSN No. : 2583-9896
Master Archive
Explore our comprehensive collection of research articles
Abstract
The short article, “CITIZEN JOURNALISM IN INDIA: A LEGAL ANALYSIS,” examines the concept and significance of citizen journalism within India’s constitutional and legal framework. It explores the constitutional protection of freedom of speech and expression and its evolution through judicial precedents. Furthermore, it analyses the absence for special privileges for citizen journalists, legal boundaries, and […]
Abstract
The blog, “BLOCKCHAIN BEYOND CRYPTO: THE NEW FACE OF BUSINESS OPERATIONS,” explores the concept of blockchain technology and its application in business apart from cryptocurrency. It examines how blockchain can improve transparency, security, efficiency, and accountability in business operations. The blog also discusses the challenges associated with its adoption, highlighting the need to address practical […]
Abstract
The research paper, “ENVIRONMENTAL JUSTICE IN INDIA: A CONCEPTUAL ANALYSIS,” examines the evolution and significance of environmental justice in India through the principles focusing on distributive, procedural, and recognition justice. It explores how environmental inequalities affect human rights, vulnerable communities, and access to justice. The study tracks the historical development of environmental justice, environmental challenges, […]
Abstract
The blog, “THE RISE OF INVISIBLE BANKING: A LEGAL ANALYSIS” examines the concept of embedded finance and its role in transforming India’s digital payments ecosystem. It analyses the legal framework governing digital payments and banking, tracing India’s shift towards a digital finance system. Using relevant arguments and evidence, the blog explores associated risks, regulatory challenges, […]
Abstract
International commercial arbitration is often presented as a neutral and enforceable method of resolving disputes arising from cross-border trade. For micro, small and medium enterprises (MSMEs), however, its practical value depends on more than the legal availability of a forum or the international enforceability of an award. Tribunal fees, institutional charges, legal representation, translation, travel, […]
Abstract
Legal professional privilege is more than a rule excluding evidence: it helps make effective legal advice possible by allowing clients to communicate candidly with advocates without a reasonable fear that those communications will later be used against them. In India, the privilege is principally reflected in sections 132–134 of the Bharatiya Sakshya Adhiniyam, 2023 (BSA), […]
Abstract
The Bharatiya Sakshya Adhiniyam, 2023 (BSA) replaced the Indian Evidence Act, 1872 (IEA) and transformed Indian Evidence Law while maintaining all the establishing rules concerning burden of proof and treatment of presumptions. This research blog examines the relationship between burden of proof rules and presumption of innocence, with particular attention to reverse-onus provisions and electronic […]
Abstract
A criminal trial is meant to discover what happened and that to fairly. Evidence may appear useful to the prosecution and still raise serious questions about coercion, reliability, privacy or the fairness of the process. The significant question is that, whether a piece of evidence helps prove a case; it is also whether the law […]
Abstract
The landmark Supreme Court of India judgment in Novartis AG v. Union of India serves as a critical precedent in pharmaceutical patent law, establishing robust legal safeguards against patent evergreening. The dispute arose from Novartis AG’s patent application for the beta crystalline form of Imatinib Mesylate—an anti-cancer medication—which was rejected by the Indian Patent Office […]
Abstract
The landmark Supreme Court of India judgment in Novartis AG v. Union of India serves as a critical precedent in pharmaceutical patent law, establishing robust legal safeguards against patent evergreening. The dispute arose from Novartis AG’s patent application for the beta crystalline form of Imatinib Mesylate—an anti-cancer medication—which was rejected by the Indian Patent Office […]